The Impact of Biomaterial Cell Contact on the Immunopeptidome.

biocompatibility biocompatibility assay biomaterials foreign body response host response immunopeptidomics mass spectrometry monocytes

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2020
Historique:
received: 10 06 2020
accepted: 19 11 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

Biomaterials play an increasing role in clinical applications and regenerative medicine. A perfectly designed biomaterial should restore the function of damaged tissue without triggering an undesirable immune response, initiate self-regeneration of the surrounding tissue and gradually degrade after implantation. The immune system is well recognized to play a major role in influencing the biocompatibility of implanted medical devices. To obtain a better understanding of the effects of biomaterials on the immune response, we have developed a highly sensitive novel test system capable of examining changes in the immune system by biomaterial. Here, we evaluated for the first time the immunopeptidome, a highly sensitive system that reflects cancer transformation, virus or drug influences and passes these cellular changes directly to T cells, as a test system to examine the effects of contact with materials. Since monocytes are one of the first immune cells reacting to biomaterials, we have tested the influence of different materials on the immunopeptidome of the monocytic THP-1 cell line. The tested materials included stainless steel, aluminum, zinc, high-density polyethylene, polyurethane films containing zinc diethyldithiocarbamate, copper, and zinc sulfate. The incubation with all material types resulted in significantly modulated peptides in the immunopeptidome, which were material-associated. The magnitude of induced changes in the immunopeptidome after the stimulation appeared comparable to that of bacterial lipopolysaccharides (LPS). The source proteins of many detected peptides are associated with cytotoxicity, fibrosis, autoimmunity, inflammation, and cellular stress. Considering all tested materials, it was found that the LPS-induced cytotoxicity-, inflammation- and cellular stress-associated HLA class I peptides were mainly induced by aluminum, whereas HLA class II peptides were mainly induced by stainless steel. These findings provide the first insights into the effects of biomaterials on the immunopeptidome. A more thorough understanding of these effects may enable the design of more biocompatible implant materials using

Identifiants

pubmed: 33392160
doi: 10.3389/fbioe.2020.571294
pmc: PMC7773052
doi:

Types de publication

Journal Article

Langues

eng

Pagination

571294

Informations de copyright

Copyright © 2020 Ghosh, Hartmann, Jakobi, März, Bichmann, Freudenmann, Mühlenbruch, Segan, Rammensee, Schneiderhan-Marra, Shipp, Stevanović and Joos.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ann Biomed Eng. 2014 Jul;42(7):1508-16
pubmed: 24248559
Science. 1992 Mar 6;255(5049):1264-6
pubmed: 1546329
Biomaterials. 2004 Jan;25(2):295-304
pubmed: 14585717
Mol Cell Proteomics. 2020 Mar;19(3):432-443
pubmed: 31937595
Immunol Res. 2017 Feb;65(1):120-128
pubmed: 27406737
Arch Ophthalmol. 2001 Oct;119(10):1417-36
pubmed: 11594942
World J Clin Cases. 2015 Jan 16;3(1):52-7
pubmed: 25610850
Tissue Eng Part A. 2015 May;21(9-10):1539-51
pubmed: 25604072
J Neurosci. 2014 Aug 13;34(33):11159-72
pubmed: 25122912
Mol Nutr Food Res. 2015 May;59(5):991-9
pubmed: 25656040
Mol Syst Biol. 2011 Sep 27;7:533
pubmed: 21952136
Autoimmun Rev. 2015 Apr;14(4):277-85
pubmed: 25462582
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
Curr Opin Immunol. 2016 Oct;42:25-30
pubmed: 27228132
Immunol Cell Biol. 2008 Feb;86(2):139-45
pubmed: 18180798
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
Trends Immunol. 2006 Dec;27(12):573-9
pubmed: 17049307
Oncoimmunology. 2018 Feb 14;7(4):e1316438
pubmed: 29632711
Mol Cell Proteomics. 2018 Mar;17(3):533-548
pubmed: 29242379
J Exp Med. 2008 Mar 17;205(3):595-610
pubmed: 18299400
Semin Immunopathol. 2011 May;33(3):221-33
pubmed: 21271251
Nat Biotechnol. 2004 Apr;22(4):450-4
pubmed: 15004565
J Am Med Womens Assoc (1972). 1998 Winter;53(1):21-4, 40
pubmed: 9458621
Cancer Immunol Immunother. 2004 Mar;53(3):187-95
pubmed: 14758508
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
pubmed: 24226387
J Endotoxin Res. 2005;11(1):5-11
pubmed: 15826372
Biomaterials. 2012 Feb;33(6):1699-713
pubmed: 22136715
Bone. 2018 May;110:38-46
pubmed: 29355746
Biotechnol Prog. 2008 Jul-Aug;24(4):807-14
pubmed: 19194892
Immunology. 2018 Jul;154(3):331-345
pubmed: 29658117
Int Rev Cell Mol Biol. 2018;341:125-168
pubmed: 30262031
J Biomed Mater Res A. 2010 May;93(2):793-806
pubmed: 19653305
Semin Immunol. 2008 Apr;20(2):86-100
pubmed: 18162407
Lupus. 2015 Sep;24(10):1012-8
pubmed: 25813870
Semin Immunol. 2017 Dec;34:61-67
pubmed: 28855088
Biomaterials. 2014 May;35(15):4477-88
pubmed: 24589361
Acta Biomater. 2012 Oct;8(10):3606-17
pubmed: 22705044
Cell. 1978 May;14(1):9-20
pubmed: 667938
Biomed Res Int. 2020 May 11;2020:3481549
pubmed: 32461979
Eur J Immunol. 2016 Jan;46(1):60-9
pubmed: 26467324
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
Clin Chem. 1981 Mar;27(3):493-501
pubmed: 7471403
Curr Opin Immunol. 1995 Dec;7(6):831-8
pubmed: 8679128
Exp Biol Med (Maywood). 2016 May;241(10):1084-97
pubmed: 27229903
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Sep-Oct;2(5):544-68
pubmed: 20681021
Mater Sci Eng C Mater Biol Appl. 2019 Apr;97:1036-1051
pubmed: 30678895
Sci Rep. 2016 Feb 22;6:21734
pubmed: 26898943
Mol Cell Proteomics. 2015 Mar;14(3):658-73
pubmed: 25576301
Eur J Immunol. 2017 Feb;47(2):314-326
pubmed: 27861808
Shock. 2003 Aug;20(2):154-8
pubmed: 12865660
Biomaterials. 2011 Oct;32(28):6692-709
pubmed: 21715002
Reprod Sci. 2014 Jan 15;21(7):939-947
pubmed: 24429676
Nature. 1991 May 23;351(6324):290-6
pubmed: 1709722
Biochim Biophys Acta Mol Cell Res. 2017 Jun;1864(6):850-857
pubmed: 28064000
Mol Immunol. 2005 May;42(7):833-8
pubmed: 15829271
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Biochem Biophys Res Commun. 2009 Oct 16;388(2):450-5
pubmed: 19679105
Nat Commun. 2016 Nov 21;7:13404
pubmed: 27869121
Arch Biochem Biophys. 2016 Dec 1;611:58-65
pubmed: 27021581
J Funct Biomater. 2019 Jul 12;10(3):
pubmed: 31336893
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3112-3117
pubmed: 30718433
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3032-5
pubmed: 7708769
Clin Immunol. 2009 Dec;133(3):353-63
pubmed: 19786367
Curr Opin Pharmacol. 2019 Aug;47:20-26
pubmed: 30831470
J Nutr Biochem. 2015 Nov;26(11):1103-15
pubmed: 26342943
Mol Ther Oncolytics. 2018 Dec 31;12:147-161
pubmed: 30775418
Wiley Interdiscip Rev RNA. 2014 May-Jun;5(3):301-15
pubmed: 24375939
Res Immunol. 1992 Jan;143(1):11-5
pubmed: 1373512
Trends Biotechnol. 2014 Dec;32(12):627-36
pubmed: 25450043
Int J Mol Sci. 2019 Feb 01;20(3):
pubmed: 30717232
Acta Biomater. 2011 Jan;7(1):278-86
pubmed: 20709200
Methods Mol Biol. 2019;1988:137-147
pubmed: 31147938

Auteurs

Michael Ghosh (M)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.

Hanna Hartmann (H)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Meike Jakobi (M)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Léo März (L)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.

Leon Bichmann (L)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
Applied Bioinformatics, Center for Bioinformatics, University of Tübingen, Tübingen, Germany.

Lena K Freudenmann (LK)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.

Lena Mühlenbruch (L)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.

Sören Segan (S)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Hans-Georg Rammensee (HG)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.
Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.

Nicole Schneiderhan-Marra (N)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Christopher Shipp (C)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Stefan Stevanović (S)

Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.
Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.

Thomas O Joos (TO)

NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.

Classifications MeSH